Clinical Trial Update: Determination of a Questionnaire After Treatment With Pantoprazole at Full Dose and Half Dose in Adult Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/UK-506) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating a questionnaire after pantoprazole treatment at full and half doses in adults with gastroesophageal reflux disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Pantoprazole (pantoprazole)

Snippet

Sponsor: Takeda | Conditions: Gastroesophageal Reflux, GERD | Phase 4 | Status: COMPLETED